Delivery Order SPE2DB24D8003-SPE2DB24FJTER
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,312.08, is a firm fixed-price delivery order for the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used to treat diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA Troop Support...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $1,230.60 and a period of performance extending through November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) identified as SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a period of performance through January 24, 2025 and a ceiling value of $2,585.80. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,661.99 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This delivery order falls under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,702.81 and a period of performance through March 24, 2025. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a $5,008.76 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medical supplies. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division's ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
This federal contract award, valued at $2,477.84, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract is structured as a firm fixed-price delivery order with a completion date of September 10, 2024. Dakota Drug, Inc. also holds a larger Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $3,816.82, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML medical supplies. The contract has a ceiling value of $1,730.35 and a period of performance through December 26, 2023. This award is under Dakota Drug's existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,039.84 and a period of performance through October 21, 2024. Dakota Drug, Inc. is also the holder of a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...